GSK said Friday that it would hold a drive-through symposium at Jamsil Drive-in Movie Theater in southern Seoul on May 21, to share the latest treatment knowledge on respiratory diseases, including asthma and whooping cough.
The symposium consists of two sessions. The first session will cover the coughing for each disease and diagnosis method for asthma on the topic of the lies and truth of chronic cough. The second session will introduce pertussis and its latest treatment.
|A poster publicizes GSK’s drive-thru symposium on respiratory disease at Jamsil Drive-in Movie Theater in southern Seoul on May 21.|
The symposium will apply a drive-through method where participants attend it inside their vehicle, in cooperation with the daily life quarantine policy to prevent the spread of Covid-19, the company said. It designed the symposium as a drive-through format, which minimizes contact between participants. Medical professionals will be able to participate in the symposium without fear of infection, it added.
At the scene, the speaker will lead the lecture in real-time, and attendees will listen to the lecture by adjusting the radio frequency while watching the presentation displaying on the screen on stage.
GSK Marketing Director Lee Kyu-nam said that although the social distancing campaign was switched to daily life quarantine from Wednesday, the company decided to adopt the drive-thru formula in keeping with the restrictive atmosphere.
“GSK will continue to consider new ways of communication to comply with government guidelines while providing useful information to medical workers who are interested in respiratory diseases,” Lee added.
Considering the current situation, which makes it difficult to provide information through face-to-face meetings, GSK has increased the share of personalized one-on-one digital content production by nearly four times for communicating without difficulty.
Also, the company has been revitalizing the sharing of digital platforms with medical professionals through webinars, holding 36 such events to draw 2,000 participants for four weeks, the company said.
<© Korea Biomedical Review, All rights reserved.>